This report describes a procedure for measuring the extensor thrust re
sponse (ETR) and summarizes the results of initial validation experime
nts using adult Long-Evans rats. The ETR can be quickly elicited and t
he force measured by pressing against the hindlimb footpads with a sma
ll rectangular plate or bar attached to a digital force gauge. Output
of the force gauge is analyzed and displayed with commercially availab
le hardware and software. The first experiment compared the acute effe
cts of TP injection of chlorpromazine (CPZ; 1, 4, or 7 mg/kg) or amphe
tamine (AMP; 0.3, 1, or 3 mg/kg) on the ETR and forelimb/hindlimb grip
strength (FL/HL-GS) in male and female rats. CPZ decreased both ETR a
nd FL/HL-GS values. Both 1 and 3 mg/kg AMP increased grip strength val
ues but decreased ETR values. A second experiment compared the evoluti
on of changes in ETR, FL/HL-GS, and peripheral neurophysiological meas
ures during 8 weeks of daily oral dosing of 10 mg/kg acrylamide (ACR)
monomer. ACR-treated rats exhibited a progressive decrease in ETR begi
nning after 3 weeks of dosing, whereas a reduction of HL-GS was observ
ed beginning much later, after 7 weeks of dosing. The deficit in ETR p
rogressed in the absence of any changes in spontaneous or evoked elect
rophysiological abnormalities in neuromuscular function, but was accom
panied by a decrease in peripheral nerve conduction velocity. Taken to
gether, the results indicate that the ETR can be used to characterize
functional effects in both single dose and repeated dose experiments.
The data also indicate that the ETR does not merely duplicate the info
rmation provided by FL/HL-GS, and suggest a hypothesis that the ETR ma
y be sensitive to neurotoxicant-induced changes in somatosensory funct
ion. (C) 1997 Elsevier Science Inc.